Search - tctmd.com

Displaying 61 - 80 of 177

Sort: Relevancy | Date

Presentation TCT 2022

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Presenter: Ahmed Altibi

September 17, 2022

Presentation TCT 2022

Cerebral Embolic Protection: Why, When, and Who?

Presenter: Axel Linke

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

Presentation TCT 2021

Captis: Full-Body Embolic Protection Device

Presenter: Haim Danenberg

November 04, 2021

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

Presenter: Craig Basman

October 14, 2020

Presentation TCT 2020

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

Presenter: Michael Dwyer

October 14, 2020

Presentation TCT 2020

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

Presenter: Denny Wang

October 14, 2020

Presentation TCT 2020

TCT 366: Role of Embolic Protection Devices in Reducing Major Adverse Limb Events in Femoropopliteal Arterial Interventions in a Matched Cohort of Patients With Critical Limb Ischemia: Results From the XLPAD Registry.

Presenter: Qais Radaideh

October 14, 2020

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

Aortic Valve Intervention and Ancillary Solutions II - Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Presentation TCT 2019

Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Presenter: Scott Russell

September 25, 2019

Aortic Valve Intervention and Ancillary Solutions I: Featured Technological Trends - Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presentation TCT 2019

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presenter: Axel Linke

September 25, 2019

Presentation TCT 2019

TCT 24: Clinical predictors for procedural stroke and implications for embolic protection device during TAVI: Results from the multicenter Transcatheter Aortic valve implantation in-hoSpital stroKe (TASK) study

Presenter: Amit Segev

September 25, 2019

Presentation TCT 2019

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Presenter: Nicolas van Mieghem

September 25, 2019

Presentation TCT 2019

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Presenter: Peter Schneider

September 25, 2019

Advertisement

TCT 324: Cerebral Embolic Protection Devices and Outcomes of Transcatheter Aortic Valve Replacement: Insight from National Readmission Database 2017-2019.

Cerebral Embolic Protection: Why, When, and Who?

New Faces, New Formats, New Tech: What to Expect From TCT 2022

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Captis: Full-Body Embolic Protection Device

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance

TCT 471: A Novel Computed Tomographic Angiography Tortuosity Index to Predict Successful Sentinel Cerebral Embolic Protection Delivery for Transcatheter Aortic Valve Replacement

TCT 366: Role of Embolic Protection Devices in Reducing Major Adverse Limb Events in Femoropopliteal Arterial Interventions in a Matched Cohort of Patients With Critical Limb Ischemia: Results From the XLPAD Registry.

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Total Embolic Protection: The Emboliner Embolic Protection Catheter, Early Clinical Results

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

TCT 24: Clinical predictors for procedural stroke and implications for embolic protection device during TAVI: Results from the multicenter Transcatheter Aortic valve implantation in-hoSpital stroKe (TASK) study

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content